Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-01-14
2010-02-16
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S406000
Reexamination Certificate
active
07662825
ABSTRACT:
The invention provides N-pyrazinyl-phenyl-sulphonamides of formula (I) for use in the treatment of chemokine mediated diseases. Particularly inflammatory diseases, such as asthma.
REFERENCES:
patent: 7410972 (2008-08-01), Baxter et al.
patent: 2002/0143024 (2002-10-01), Murugesan et al.
patent: 2006/0122195 (2006-06-01), Harrison et al.
patent: 2006/0128723 (2006-06-01), Mete et al.
patent: 2006/0189613 (2006-08-01), Cheshire et al.
patent: 2007/0093491 (2007-04-01), Baxter et al.
patent: 2008/0293742 (2008-11-01), Cheshire et al.
patent: 0713875 (2001-03-01), None
patent: 0749964 (2001-10-01), None
patent: 2295616 (1996-06-01), None
patent: 95/26957 (1995-10-01), None
patent: WO 95/26957 (1995-10-01), None
patent: WO 98/13366 (1998-04-01), None
patent: WO 00/01389 (2000-01-01), None
patent: WO 01/44239 (2001-06-01), None
patent: WO 03/051870 (2003-06-01), None
patent: 2004/007472 (2004-01-01), None
patent: WO 2004/007472 (2004-01-01), None
patent: WO 2004/108690 (2004-12-01), None
patent: WO 2004/108692 (2004-12-01), None
patent: WO 2004/108717 (2004-12-01), None
patent: WO 2005/021513 (2005-03-01), None
patent: WO 2007/035154 (2007-03-01), None
patent: WO 2007/069978 (2007-06-01), None
Daniels, et. al., Journal of the American Chemical Society (1941), 63, 257-8.
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.
Vippagunta et. al. Advanced Drug Delivery Reviews 48 (2001) 3-26.
Esche, J. et al., “Reaction products formed by bromometric titration of several sulfonamides of the pyridazine, pyrazine, and pyrazoteseries”; & Arch. Pharm. 1966,299 2,147-53.
STN International, File CAPLUS, CAPLUS accession No. 2000:34745, Document No. 132:93309, Bristol-Myers Squibb Bo.: “Preparation of N-isoxazolyl biphenylsulfonamides and related compounds as dual angiotension II and endothelin receptor antagonists” & WO, A1, 2000001389, 20000113, see compound with CAS RN 25475-89-9.
STN International, File HCAPLUS, HCAPLUS accession No. 1982:484681: Document No. 97:84681, Kivman, G. Ya. et al: “Penetration of sulfanilamides into inflammatory foci”; & Khim.-Farm. Zh. (1982), 16(6), 665-7.
STN International, File CAPLUS, CAPLUS accession No. 1966:84579, Document No. 64:84579, Esche, J. et al.: “Reaction products formed by bromometric titration of several sulfonamides of the pyridazine, pyrazine, and pyrazole series”; & Arch. Pharm. (1966), 299(2), 147-53.
Baxter Andrew
Johnson Timothy
Kindon Nicholas
Roberts Bryan
Stocks Michael
AstraZeneca AB
Morgan & Lewis & Bockius, LLP
Murray Jeffrey H
Wilson James O
LandOfFree
N-pyrazinyl-phenylsulphonamides and their use in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-pyrazinyl-phenylsulphonamides and their use in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-pyrazinyl-phenylsulphonamides and their use in the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4168136